Login / Signup

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.

Qi-Jiong LiMin-Ke HeHuan-Wei ChenWan-Qiang FangYuan-Min ZhouLi XuWei WeiYao-Jun ZhangYing GuoRong-Ping GuoMin-Shan ChenMing Shi
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
FOLFOX-HAIC significantly improved overall survival over TACE in patients with unresectable large hepatocellular carcinoma.
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • phase ii
  • double blind
  • liver metastases
  • radiofrequency ablation
  • placebo controlled
  • low dose
  • squamous cell carcinoma
  • locally advanced
  • radiation therapy
  • free survival